The aim of the research is to evaluate the reliability of bone resorption biomarkers called Pyridinium Crosslinks (Pyd) in the urine of the neonates as an evaluation to bone growth of the neonate, as an indicator of stunting. Study Design: A cross-sectional study. Place and Duration of Study: Andini Mothers and Children Hospital (Pekanbaru, Indonesia). Duration of the study was between, August until September 2014. Methodology: Subjects of study were 35 healthy neonates. Subjects were recruited at the first 3 days of life. Body length gauges, digital weighting scale, family socioeconomic questionnaires and Pyd kit were used to collect the data. Differences in the mean of the research variables were tested using an Independent t-test. Hayati et al.; AJRIMPS, 7(1): 1-8, 2019; Article no.AJRIMPS.48579 2 Results: Results showed that there were significant differences (p<0.01) in terms of height for age and Pyd in the urine of stunted (body length <48 cm) versus normal (body length ≥48 cm) neonates. The contents of Pyd in the urine of stunted neonates were 982.9±61.6 and normal neonates was 594.1±266.1 nmol/mmol. Conclusion: Therefore, there is a possible association between height for age and Pyd in the urine as a potential early indicators to identify stunted and normal neonates.
INTRODUCTION
Stunting is a condition by which an individual failed to reach the linear growth potential which could be resulted from the conditions of their health and nutrition [1] . Worldwide, childhood stunting declined from 39.7% in 1990 to 26.7% in 2010 [2] . This expected to incline towards 21.8%, or 142 million, in the year 2020 [2] . In Indonesia, stunting is one of the major nutrition problems in Indonesia, with the prevalence of 35.6% [3] . Stunting is resulted from poor standard of living, exposure to adverse conditions such as diseases and poor eating habits and practices [1] . The most common cause of stunting in the developing countries includes: Impaired absorption of nutrients due to intestinal infections or parasites; or combinations of these problems [4, 5] . Stunting may also lead to several long-term effects when they reach adulthood period, which includes poor cognitive development, poor in academic, poor productivity towards the economy and negative impact on the reproductive health [4] .
Improved early nutrition and care can compensate in part for stunted in utero. Stunting that began at a very early infancy age, leads to a more severe impairment to their cognitive development in later life [4] . Therefore, an early determination of stunting among neonates is very important in order to support for proper feeding support and the gain of better optimal health [6] . The use of classical anthropometric measurements for body length measurements is widely accepted since many decades ago [7] . However, the use of such measurements to determine stunting has drawbacks such as possible human error or issues with the devices. The use of biomarkers in radiology is being debated to measure the infant's bone density to monitor the growth of the baby; however this method is deemed unsuitable as it involves unnecessary invasive procedures for the babies. Therefore, the use of other readily obtained biological fluids or wastes such as urine can be used as a possible early indicator to stunting among neonates.
In this research, the quantification of a bone resorption marker called Pyd in the urine as a possible early indicator to stunting is proposed [8] . The condition of the urine is associated with health condition of the kidney. Stunted babies (that has been exposed to malnutrition) has shown to have disruption to their metabolic processes and increased risk of renal impairment [9] . In order to find out whether the babies are having these issues, the creatinine level can be measured from their urine. Creatinine is derived from the metabolism of proteins, either from food or from muscle. Human bone is formed through the process of pairing between bone resorption process (release of a cell or tissue with a gradual preparation of the compounds into smaller and dispersed in circulation) by osteoclasts and bone formation by osteoblast. This process happens normally in bone and skeletal growth. As many as 90% of the organic matrix of bone is made of Collagen Type I is a helical protein is stabilized by cross-linking between terminals N and C terminals on the basis of the formation of bone tissue.
During maturation of collagen, Pyd formed by hydroxy Lysine or Lysine residues at the end of the C-and N-terminal telopeptide of collagen molecules and is released during the resorption of the matrix and is excreted through the urine. Pyd is expected to be specific and sensitive biomarker of bone resorption and are able to evaluate bone metabolism or disorder in neonates.
Based on the biological processes, Pyd seems to be of potential use to evaluate bone metabolism among neonates, which may indirectly indicate the possibility of stunting condition. Therefore, the main objective of the study is to test the possibility of Pyd level in urine as an early indicator to stunting.
MATERIALS AND METHODS
The study design was cross-sectional and was conducted between January to December 2014. Subjects of the study were 35 healthy neonates born at the Andini's Mothers and Children Hospital at Tuanku Tambusai street 55, Pekanbaru (middle class hospital and population strategic location in Pekanbaru) between the 28 th of August until 30 th September 2014 (all babies born in a specific period of time that their mothers were willing to sign an informed consent). The minimum number of samples to compare two groups (stunted & normal) in this study is 30,29 neonates [10] . n = Sample size σ = Population standard deviation μ 1 = Test value of the population mean μ 2 = Anticipated population mean The value of α = 5% (1.964) and β = 20% (0.842) [11] . In order to obtain a number of samples that reflect population characteristics, statistical parameters (eg mean and standard deviation) from previous studies were used in this study. The research was "Food Supplementation with Encouragement to Feed It to Infants from 4 to 12 Months of Age" carried out by [12] . The study showed that μ1 -μ2 = 0.4 cm (achievement of the subject body length increase), and standard deviation namely σ = 1.6 cm. In anticipation of the drop out subjects, a number of neonates were added so that n = 35 neonates. Subjects were recruited at around 1-3 days of neonatal life. Inclusion criteria were normal gestation (36 to 40 weeks), spontaneous and caesarean delivery. The 24-hours neonates' urine was collected using pediatrics urine bags by trained nurses, aliquoted to 6 mL. Mothers were briefed about the study, one day prior to neonates urine collection. Baby urine that has been collected was stored in the refrigerator at a temperature of -20°C at the Pekanbaru Prodia Clinical Laboratory and then was sent to Prodia Center in Jakarta for analysis.
Statistical analysis and results are reported based on the data. Statistical outliers, defined as outside the 95% confidence limits of the normal probability plots, two subjects were removed before the analysis.
In all statistical tests performed, the null hypothesis (no effect) was rejected at the 0.01 level of probability. Differences in mean body weight, head circumference, concentrations of Pyd urine, age, weight-for-age-z-score (WAZ), length/height-forage (HAZ), basal metabolic index (BMI) for age (BAZ), mother's height, mother's BMI, mother's weight before pregnancy, mother's prenatal weight, mother's pregnancy age, the number of children in family were evaluated by using a Independent t-test. Stunted neonates referred to babies with body length of <48 cm and normal babies referred to those with body length ≥48 [13] .
All analyses were performed by using SPSS version 20 (IBM SPSS Statistics 20).
RESULTS AND DISCUSSION
The proportion of stunted neonates in the study was 22.9%. That is similar with reported by [13] that the proportion of stunting neonates in Indonesia is 20.2%.
All neonates were healthy and have received full enteral feeding (formula and/or breast feeding). 74.3% and 25.7% of the subjects involved in the study were male and female respectively ( Table  1) . It was found to be much easier to collect urine from male than female neonates, which reflected on the higher percentage of the subjects. Most of the mothers stayed at Pekanbaru, except for two of them. This is because their other family members also stayed at the same area and would like to be close to them when their baby is born. Apart from that, living at Pekanbaru, the mothers thought that they can get a proper medical attention when needed compared to outside the city. Most of the mothers were Malay and a small percentage was Chinese. 50% of the subject's mother was full housewife. Some of the mothers were also working as officers of the government and private Table 1 . Growth problems Note 4: It is possible for a stunted or severely stunted child to become overweight [14] sector. Overall, the education level among all the subjects mothers were from the Elementary to Scholar level.
Length for age males and female neonates in Indonesia is about same. [15] reported that length male neonatus is 49.9 cm and female neonatus is 49.1 cm. The growth of male and female neonates is almost the same in the early stages of life, differences will occur at the next stage of growth [16] . There were 42 neonates who were born during the urine collection period, as many as 5 neonates were not continued to be processed to the analysis stage of the urine Pyd content because the amount of urine collected was insufficient. The five neonates are female.
Neonatal female urine collectors are relatively more difficult than men because female urine sometimes spills out of a pediatric urine collector. An addition, there were 2 female neonates whose Pyd content was in the form of outliers so they were not included in the data analysis.
The proportion of stunted neonates in the study was 22.9%. It was a similar findings as reported by Atmarita research which was at the rate of 20.2% [13] . The characteristics of the stunted and normal subject were recorded as Table 2 .
The length of stunted and normal neonates was 46.8±0.5 cm and 49.9±1.4 respectively. Their weight also differs, by which the normal neonates were much heavier compared to the stunted neonates (a difference of about 300-400 g). The head circumference of stunted neonates and normal neonates were 33.3±1.0 and 33.6±1.2cm respectively. This study has shown that there was a major difference (statistically significance) in terms of the level of Pyd in the urine between the stunted neonates and normal neonates. Among stunted neonates, the amount of Pyd in the urine was 982.9±61.6 nmol/mmol Cr, compared to only 594.1±266.1 among normal neonates. The HAZ was also found to be statistically significant between the stunted neonates and normal neonates.
Mothers of subjects with small BMI's did not give birth small subjects (independent t test). The mean BMI of mothers of stunting and normal subjects were 22.2 and 20.0, respectively. The mother of the subject with a normal BMI was 48.3% ( Table 4 ).
Classification of adult Asian body mass index (BMI) according to [14] is listed in Table 5 .
The quantified amount of Pyd in the urine of the neonates had quadratic relationship with HAZ ('U-shaped' scatter plot) as shown in Fig. 1 . The Pyd in the urine was negatively associated with body length in stunted neonates and can be used as biomarkers of linear growth. Neonates classified as stunted if their length <48 cm and the contents of Pyd>859.7 nmol/mmol Cr. Further study is recommended for infants aged 6 to 12 months to further confirm the hypothesis. In the previous studies, Pyd excretion were found to differ based on different age groups. Pyd excretion from elementary school children, for example, is about 50--500 nmol/mmol Cr [17] . Pyd excretion on children 3-5 year was 238.3±22.7 pmol/mumol Cr (male) and 261.8±14.2 pmol/mumol Cr (female) [18] . 
CONCLUSION
Pyd was significantly higher in the urine from stunted neonates than non-stunted neonates. Urine Pyd may become a candidate of a marker of stunted neonates. Further study on a large population is necessary.
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